Renalytix PLC
(NASDAQ:RNLX)
$3.01
-0.26[-7.95%]
Last update: 12:51PM (Delayed 15-Minutes)
Get Real Time Here
Day Range2.965 - 3.30052 Wk Range1.050 - 13.910Open / Close3.220 / -Float / Outstanding- / 37.446M
Vol / Avg.84.666K / 75.071KMkt Cap112.712MP/E-50d Avg. Price2.100
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.600

Renalytix Stock (NASDAQ:RNLX), Quotes and News Summary

Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.965 - 3.30052 Wk Range1.050 - 13.910Open / Close3.220 / -Float / Outstanding- / 37.446M
Vol / Avg.84.666K / 75.071KMkt Cap112.712MP/E-50d Avg. Price2.100
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.600
Globe Newswire - Nov 3, 2022, 7:00AM
Globe Newswire - Oct 31, 2022, 7:00AM
Globe Newswire - Sep 20, 2022, 7:00AM
Globe Newswire - Apr 8, 2022, 7:00AM
Globe Newswire - Mar 31, 2022, 7:05AM
TipRanks - Dec 2, 2022, 10:05PM
Seeking Alpha - Nov 30, 2022, 1:26PM
InvestorsObserver - Nov 30, 2022, 10:09AM
TipRanks - Nov 2, 2022, 1:15AM
Seeking Alpha - Oct 31, 2022, 6:09PM
Seeking Alpha - Oct 31, 2022, 11:55AM
InvestorsObserver - Sep 6, 2022, 8:40AM
Seeking Alpha - Jul 25, 2022, 2:16AM
TalkMarkets - Jun 30, 2022, 12:23PM
InvestorsObserver - Jun 30, 2022, 11:43AM
Sector: Health Care.Industry: Health Care Technology
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Earnings

see more
Q2 2023Est.ActualSurprise
EPS
(EXPECTED)2023-03-30
REV
Q1 2023Est.ActualSurprise
EPS-0.130-0.160 -0.0300
REV1.100M969.000K-131.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Renalytix (RNLX) stock?

A

You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Renalytix's (RNLX) competitors?

Q

What is the target price for Renalytix (RNLX) stock?

A

The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Renalytix (RNLX)?

A

The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.

Q

Does Renalytix (RNLX) pay a dividend?

A

There are no upcoming dividends for Renalytix.

Q

When is Renalytix (NASDAQ:RNLX) reporting earnings?

A

Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.

Q

Is Renalytix (RNLX) going to split?

A

There is no upcoming split for Renalytix.

Q

What sector and industry does Renalytix (RNLX) operate in?

A

Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.

Renalytix Stock (NASDAQ:RNLX), Quotes and News Summary

Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.965 - 3.30052 Wk Range1.050 - 13.910Open / Close3.220 / -Float / Outstanding- / 37.446M
Vol / Avg.84.666K / 75.071KMkt Cap112.712MP/E-50d Avg. Price2.100
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.600
Globe Newswire - Nov 3, 2022, 7:00AM
Globe Newswire - Oct 31, 2022, 7:00AM
Globe Newswire - Sep 20, 2022, 7:00AM
Globe Newswire - Apr 8, 2022, 7:00AM
Globe Newswire - Mar 31, 2022, 7:05AM
TipRanks - Dec 2, 2022, 10:05PM
Seeking Alpha - Nov 30, 2022, 1:26PM
InvestorsObserver - Nov 30, 2022, 10:09AM
TipRanks - Nov 2, 2022, 1:15AM
Seeking Alpha - Oct 31, 2022, 6:09PM
Seeking Alpha - Oct 31, 2022, 11:55AM
InvestorsObserver - Sep 6, 2022, 8:40AM
Seeking Alpha - Jul 25, 2022, 2:16AM
TalkMarkets - Jun 30, 2022, 12:23PM
InvestorsObserver - Jun 30, 2022, 11:43AM
Sector: Health Care.Industry: Health Care Technology
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Earnings

see more
Q2 2023Est.ActualSurprise
EPS
(EXPECTED)2023-03-30
REV
Q1 2023Est.ActualSurprise
EPS-0.130-0.160 -0.0300
REV1.100M969.000K-131.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Renalytix (RNLX) stock?

A

You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Renalytix's (RNLX) competitors?

Q

What is the target price for Renalytix (RNLX) stock?

A

The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Renalytix (RNLX)?

A

The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.

Q

Does Renalytix (RNLX) pay a dividend?

A

There are no upcoming dividends for Renalytix.

Q

When is Renalytix (NASDAQ:RNLX) reporting earnings?

A

Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.

Q

Is Renalytix (RNLX) going to split?

A

There is no upcoming split for Renalytix.

Q

What sector and industry does Renalytix (RNLX) operate in?

A

Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.

Renalytix Stock (NASDAQ:RNLX), Quotes and News Summary

Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.965 - 3.30052 Wk Range1.050 - 13.910Open / Close3.220 / -Float / Outstanding- / 37.446M
Vol / Avg.84.666K / 75.071KMkt Cap112.712MP/E-50d Avg. Price2.100
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.600
Globe Newswire - Nov 3, 2022, 7:00AM
Globe Newswire - Oct 31, 2022, 7:00AM
Globe Newswire - Sep 20, 2022, 7:00AM
Globe Newswire - Apr 8, 2022, 7:00AM
Globe Newswire - Mar 31, 2022, 7:05AM
TipRanks - Dec 2, 2022, 10:05PM
Seeking Alpha - Nov 30, 2022, 1:26PM
InvestorsObserver - Nov 30, 2022, 10:09AM
TipRanks - Nov 2, 2022, 1:15AM
Seeking Alpha - Oct 31, 2022, 6:09PM
Seeking Alpha - Oct 31, 2022, 11:55AM
InvestorsObserver - Sep 6, 2022, 8:40AM
Seeking Alpha - Jul 25, 2022, 2:16AM
TalkMarkets - Jun 30, 2022, 12:23PM
InvestorsObserver - Jun 30, 2022, 11:43AM
Sector: Health Care.Industry: Health Care Technology
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Earnings

see more
Q2 2023Est.ActualSurprise
EPS
(EXPECTED)2023-03-30
REV
Q1 2023Est.ActualSurprise
EPS-0.130-0.160 -0.0300
REV1.100M969.000K-131.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Renalytix (RNLX) stock?

A

You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Renalytix's (RNLX) competitors?

Q

What is the target price for Renalytix (RNLX) stock?

A

The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Renalytix (RNLX)?

A

The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.

Q

Does Renalytix (RNLX) pay a dividend?

A

There are no upcoming dividends for Renalytix.

Q

When is Renalytix (NASDAQ:RNLX) reporting earnings?

A

Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.

Q

Is Renalytix (RNLX) going to split?

A

There is no upcoming split for Renalytix.

Q

What sector and industry does Renalytix (RNLX) operate in?

A

Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.

Renalytix Stock (NASDAQ:RNLX), Quotes and News Summary

Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.965 - 3.30052 Wk Range1.050 - 13.910Open / Close3.220 / -Float / Outstanding- / 37.446M
Vol / Avg.84.666K / 75.071KMkt Cap112.712MP/E-50d Avg. Price2.100
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.600
Globe Newswire - Nov 3, 2022, 7:00AM
Globe Newswire - Oct 31, 2022, 7:00AM
Globe Newswire - Sep 20, 2022, 7:00AM
Globe Newswire - Apr 8, 2022, 7:00AM
Globe Newswire - Mar 31, 2022, 7:05AM
TipRanks - Dec 2, 2022, 10:05PM
Seeking Alpha - Nov 30, 2022, 1:26PM
InvestorsObserver - Nov 30, 2022, 10:09AM
TipRanks - Nov 2, 2022, 1:15AM
Seeking Alpha - Oct 31, 2022, 6:09PM
Seeking Alpha - Oct 31, 2022, 11:55AM
InvestorsObserver - Sep 6, 2022, 8:40AM
Seeking Alpha - Jul 25, 2022, 2:16AM
TalkMarkets - Jun 30, 2022, 12:23PM
InvestorsObserver - Jun 30, 2022, 11:43AM
Sector: Health Care.Industry: Health Care Technology
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Earnings

see more
Q2 2023Est.ActualSurprise
EPS
(EXPECTED)2023-03-30
REV
Q1 2023Est.ActualSurprise
EPS-0.130-0.160 -0.0300
REV1.100M969.000K-131.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Renalytix (RNLX) stock?

A

You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Renalytix's (RNLX) competitors?

Q

What is the target price for Renalytix (RNLX) stock?

A

The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Renalytix (RNLX)?

A

The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.

Q

Does Renalytix (RNLX) pay a dividend?

A

There are no upcoming dividends for Renalytix.

Q

When is Renalytix (NASDAQ:RNLX) reporting earnings?

A

Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.

Q

Is Renalytix (RNLX) going to split?

A

There is no upcoming split for Renalytix.

Q

What sector and industry does Renalytix (RNLX) operate in?

A

Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.

Renalytix Stock (NASDAQ:RNLX), Quotes and News Summary

Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.965 - 3.30052 Wk Range1.050 - 13.910Open / Close3.220 / -Float / Outstanding- / 37.446M
Vol / Avg.84.666K / 75.071KMkt Cap112.712MP/E-50d Avg. Price2.100
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.600
Globe Newswire - Nov 3, 2022, 7:00AM
Globe Newswire - Oct 31, 2022, 7:00AM
Globe Newswire - Sep 20, 2022, 7:00AM
Globe Newswire - Apr 8, 2022, 7:00AM
Globe Newswire - Mar 31, 2022, 7:05AM
TipRanks - Dec 2, 2022, 10:05PM
Seeking Alpha - Nov 30, 2022, 1:26PM
InvestorsObserver - Nov 30, 2022, 10:09AM
TipRanks - Nov 2, 2022, 1:15AM
Seeking Alpha - Oct 31, 2022, 6:09PM
Seeking Alpha - Oct 31, 2022, 11:55AM
InvestorsObserver - Sep 6, 2022, 8:40AM
Seeking Alpha - Jul 25, 2022, 2:16AM
TalkMarkets - Jun 30, 2022, 12:23PM
InvestorsObserver - Jun 30, 2022, 11:43AM
Sector: Health Care.Industry: Health Care Technology
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Earnings

see more
Q2 2023Est.ActualSurprise
EPS
(EXPECTED)2023-03-30
REV
Q1 2023Est.ActualSurprise
EPS-0.130-0.160 -0.0300
REV1.100M969.000K-131.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Renalytix (RNLX) stock?

A

You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Renalytix's (RNLX) competitors?

Q

What is the target price for Renalytix (RNLX) stock?

A

The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Renalytix (RNLX)?

A

The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.

Q

Does Renalytix (RNLX) pay a dividend?

A

There are no upcoming dividends for Renalytix.

Q

When is Renalytix (NASDAQ:RNLX) reporting earnings?

A

Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.

Q

Is Renalytix (RNLX) going to split?

A

There is no upcoming split for Renalytix.

Q

What sector and industry does Renalytix (RNLX) operate in?

A

Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.

Renalytix Stock (NASDAQ:RNLX), Quotes and News Summary

Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.965 - 3.30052 Wk Range1.050 - 13.910Open / Close3.220 / -Float / Outstanding- / 37.446M
Vol / Avg.84.666K / 75.071KMkt Cap112.712MP/E-50d Avg. Price2.100
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.600
Globe Newswire - Nov 3, 2022, 7:00AM
Globe Newswire - Oct 31, 2022, 7:00AM
Globe Newswire - Sep 20, 2022, 7:00AM
Globe Newswire - Apr 8, 2022, 7:00AM
Globe Newswire - Mar 31, 2022, 7:05AM
TipRanks - Dec 2, 2022, 10:05PM
Seeking Alpha - Nov 30, 2022, 1:26PM
InvestorsObserver - Nov 30, 2022, 10:09AM
TipRanks - Nov 2, 2022, 1:15AM
Seeking Alpha - Oct 31, 2022, 6:09PM
Seeking Alpha - Oct 31, 2022, 11:55AM
InvestorsObserver - Sep 6, 2022, 8:40AM
Seeking Alpha - Jul 25, 2022, 2:16AM
TalkMarkets - Jun 30, 2022, 12:23PM
InvestorsObserver - Jun 30, 2022, 11:43AM
Sector: Health Care.Industry: Health Care Technology
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Earnings

see more
Q2 2023Est.ActualSurprise
EPS
(EXPECTED)2023-03-30
REV
Q1 2023Est.ActualSurprise
EPS-0.130-0.160 -0.0300
REV1.100M969.000K-131.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Renalytix (RNLX) stock?

A

You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Renalytix's (RNLX) competitors?

Q

What is the target price for Renalytix (RNLX) stock?

A

The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Renalytix (RNLX)?

A

The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.

Q

Does Renalytix (RNLX) pay a dividend?

A

There are no upcoming dividends for Renalytix.

Q

When is Renalytix (NASDAQ:RNLX) reporting earnings?

A

Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.

Q

Is Renalytix (RNLX) going to split?

A

There is no upcoming split for Renalytix.

Q

What sector and industry does Renalytix (RNLX) operate in?

A

Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.

Renalytix Stock (NASDAQ:RNLX), Quotes and News Summary

Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.965 - 3.30052 Wk Range1.050 - 13.910Open / Close3.220 / -Float / Outstanding- / 37.446M
Vol / Avg.84.666K / 75.071KMkt Cap112.712MP/E-50d Avg. Price2.100
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.600
Globe Newswire - Nov 3, 2022, 7:00AM
Globe Newswire - Oct 31, 2022, 7:00AM
Globe Newswire - Sep 20, 2022, 7:00AM
Globe Newswire - Apr 8, 2022, 7:00AM
Globe Newswire - Mar 31, 2022, 7:05AM
TipRanks - Dec 2, 2022, 10:05PM
Seeking Alpha - Nov 30, 2022, 1:26PM
InvestorsObserver - Nov 30, 2022, 10:09AM
TipRanks - Nov 2, 2022, 1:15AM
Seeking Alpha - Oct 31, 2022, 6:09PM
Seeking Alpha - Oct 31, 2022, 11:55AM
InvestorsObserver - Sep 6, 2022, 8:40AM
Seeking Alpha - Jul 25, 2022, 2:16AM
TalkMarkets - Jun 30, 2022, 12:23PM
InvestorsObserver - Jun 30, 2022, 11:43AM
Sector: Health Care.Industry: Health Care Technology
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Earnings

see more
Q2 2023Est.ActualSurprise
EPS
(EXPECTED)2023-03-30
REV
Q1 2023Est.ActualSurprise
EPS-0.130-0.160 -0.0300
REV1.100M969.000K-131.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Renalytix (RNLX) stock?

A

You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Renalytix's (RNLX) competitors?

Q

What is the target price for Renalytix (RNLX) stock?

A

The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Renalytix (RNLX)?

A

The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.

Q

Does Renalytix (RNLX) pay a dividend?

A

There are no upcoming dividends for Renalytix.

Q

When is Renalytix (NASDAQ:RNLX) reporting earnings?

A

Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.

Q

Is Renalytix (RNLX) going to split?

A

There is no upcoming split for Renalytix.

Q

What sector and industry does Renalytix (RNLX) operate in?

A

Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.

Renalytix Stock (NASDAQ:RNLX), Quotes and News Summary

Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.965 - 3.30052 Wk Range1.050 - 13.910Open / Close3.220 / -Float / Outstanding- / 37.446M
Vol / Avg.84.666K / 75.071KMkt Cap112.712MP/E-50d Avg. Price2.100
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.600
Globe Newswire - Nov 3, 2022, 7:00AM
Globe Newswire - Oct 31, 2022, 7:00AM
Globe Newswire - Sep 20, 2022, 7:00AM
Globe Newswire - Apr 8, 2022, 7:00AM
Globe Newswire - Mar 31, 2022, 7:05AM
TipRanks - Dec 2, 2022, 10:05PM
Seeking Alpha - Nov 30, 2022, 1:26PM
InvestorsObserver - Nov 30, 2022, 10:09AM
TipRanks - Nov 2, 2022, 1:15AM
Seeking Alpha - Oct 31, 2022, 6:09PM
Seeking Alpha - Oct 31, 2022, 11:55AM
InvestorsObserver - Sep 6, 2022, 8:40AM
Seeking Alpha - Jul 25, 2022, 2:16AM
TalkMarkets - Jun 30, 2022, 12:23PM
InvestorsObserver - Jun 30, 2022, 11:43AM
Sector: Health Care.Industry: Health Care Technology
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Earnings

see more
Q2 2023Est.ActualSurprise
EPS
(EXPECTED)2023-03-30
REV
Q1 2023Est.ActualSurprise
EPS-0.130-0.160 -0.0300
REV1.100M969.000K-131.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Renalytix (RNLX) stock?

A

You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Renalytix's (RNLX) competitors?

Q

What is the target price for Renalytix (RNLX) stock?

A

The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Renalytix (RNLX)?

A

The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.

Q

Does Renalytix (RNLX) pay a dividend?

A

There are no upcoming dividends for Renalytix.

Q

When is Renalytix (NASDAQ:RNLX) reporting earnings?

A

Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.

Q

Is Renalytix (RNLX) going to split?

A

There is no upcoming split for Renalytix.

Q

What sector and industry does Renalytix (RNLX) operate in?

A

Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.

Renalytix Stock (NASDAQ:RNLX), Quotes and News Summary

Renalytix Stock (NASDAQ: RNLX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.965 - 3.30052 Wk Range1.050 - 13.910Open / Close3.220 / -Float / Outstanding- / 37.446M
Vol / Avg.84.666K / 75.071KMkt Cap112.712MP/E-50d Avg. Price2.100
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.600
Globe Newswire - Nov 3, 2022, 7:00AM
Globe Newswire - Oct 31, 2022, 7:00AM
Globe Newswire - Sep 20, 2022, 7:00AM
Globe Newswire - Apr 8, 2022, 7:00AM
Globe Newswire - Mar 31, 2022, 7:05AM
TipRanks - Dec 2, 2022, 10:05PM
Seeking Alpha - Nov 30, 2022, 1:26PM
InvestorsObserver - Nov 30, 2022, 10:09AM
TipRanks - Nov 2, 2022, 1:15AM
Seeking Alpha - Oct 31, 2022, 6:09PM
Seeking Alpha - Oct 31, 2022, 11:55AM
InvestorsObserver - Sep 6, 2022, 8:40AM
Seeking Alpha - Jul 25, 2022, 2:16AM
TalkMarkets - Jun 30, 2022, 12:23PM
InvestorsObserver - Jun 30, 2022, 11:43AM
Sector: Health Care.Industry: Health Care Technology
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Earnings

see more
Q2 2023Est.ActualSurprise
EPS
(EXPECTED)2023-03-30
REV
Q1 2023Est.ActualSurprise
EPS-0.130-0.160 -0.0300
REV1.100M969.000K-131.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Renalytix (RNLX) stock?

A

You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Renalytix's (RNLX) competitors?

Q

What is the target price for Renalytix (RNLX) stock?

A

The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, December 2, 2022. The analyst firm set a price target for 8.00 expecting RNLX to rise to within 12 months (a possible 165.78% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Renalytix (RNLX)?

A

The stock price for Renalytix (NASDAQ: RNLX) is $3.01 last updated Today at January 31, 2023 at 5:51 PM UTC.

Q

Does Renalytix (RNLX) pay a dividend?

A

There are no upcoming dividends for Renalytix.

Q

When is Renalytix (NASDAQ:RNLX) reporting earnings?

A

Renalytix’s Q2 earnings are confirmed for Thursday, March 30, 2023.

Q

Is Renalytix (RNLX) going to split?

A

There is no upcoming split for Renalytix.

Q

What sector and industry does Renalytix (RNLX) operate in?

A

Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.